Defining infection risk of bispecific antibodies for myeloma

Blood Adv. 2024 Sep 24;8(18):4977-4978. doi: 10.1182/bloodadvances.2024013813.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Bispecific* / therapeutic use
  • Humans
  • Infections / etiology
  • Infections / immunology
  • Multiple Myeloma* / immunology

Substances

  • Antibodies, Bispecific